XINHE YUANSHENG MEDICINE CO., LTD.

As the 1st manufacturer with Approval notification of Application of the drug registration, we have been dedicated to produce Trimebutine Maleate for more than 27 years. We are also one of the earliest companies who have obtained GMP Certificate since 2000. Besides, we’ve actively introduced other countries’ quality management system to foreign drug manufacturer based on local GMP Certificate. Finally we have obtained Accreditation certificate of foreign drug manufacturer and JDMF Registration Certificate in Japan and KDMF Registration in Republic of Korea and Cofepris GMP, Mexico successively after the Authorities conduct the site inspection. Meanwhile, The dedicated production line in separate workshop has been always used to produce from starting material, not any intermediate purchasing from the supply, to Trimebutine Maleate. Additionally, Trimebutine Maleate is treated as “Core product”. All result in the stable quality and consistent and normal production whatever the sub-materials are tough. Currently, we’ve met several specifications, such as JP XVIII, EP10.0, BP2020 and CP2020 etc.. We’d like to try to meet the customer’s special quality requirement(s) if any. Besides, Trimebutine Maleate Tablets, Compound Amino Acid Injection (18-AA), Compound Amino Acid Injection (17-I) and Levofloxacin Sodium Choride Injection are in demand more frequently.